Pharma companies increasingly use structured open-innovation platforms to access breakthrough science faster. Bayer Co.Lab exemplifies this: a global network of life science incubators giving start-ups labs, infrastructure, and pharma proximity to speed the path to clinic. CHEManager‘s Christene Smith spoke with Ruth Shah, Head of Bayer Co.Lab Berlin, about how the model works, its edge…
